Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa - Does feticide decrease postdelivery maternal hemorrhage?

Rodrigo Ruano, Y. Dumez, D. Cabrol, M. Dommergues

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Objective: To study the feasibility of second- and thirdtrimester termination of pregnancy (TOP) with complete placenta previa, and the impact of performing feticide before labor induction on maternal hemorrhagic morbidity. Patients and Methods: From 1987 to 2002, the databases of two referral hospitals were reviewed. We identified 15 cases of second- or third-trimester TOP in women with complete placenta previa. Feticide was performed 2-14 days before induction in 6/15 cases. Cervical ripening was achieved in 8 cases by mifepristone alone (n = 2) or by mifepristone and dilapan (n = 6). Labor was induced by vaginal gemeprost (n = 2), intramuscular (n = 5) or intravenous (n = 4) sulprostone, vaginal misoprostol (n = 1) or a combination of misoprostol and sulprostone (n = 3). Hemorrhage was defined by the need for transfusion. The difference between the preoperative and the lowest per- or postoperative maternal hemoglobin level was also analyzed. Results: Of the 9 women who underwent labor induction without previous feticide, 4 required blood transfusions, 1 of whom had a hemostat hysterectomy. The mean hemoglobin difference was 2.5 g/dl (range: 0.5-5.3). None of the 6 patients with preinduction feticide required transfusion. The hemoglobin difference was significantly smaller in this group than in terminations without previous feticide (mean: 1.0 g/dl ; range: 0.1-2.2; p = 0.03). Conclusion: In cases with complete placenta previa, second- or third-trimester TOP is feasible. It carries a substantial risk of hemorrhage that might be decreased by preinduction feticide.

Original languageEnglish (US)
Pages (from-to)475-478
Number of pages4
JournalFetal Diagnosis and Therapy
Volume19
Issue number6
DOIs
StatePublished - Nov 22 2004
Externally publishedYes

Fingerprint

Induced Labor
Placenta Previa
Third Pregnancy Trimester
Second Pregnancy Trimester
Misoprostol
Mifepristone
Hemoglobins
Mothers
Hemorrhage
Pregnancy
Cervical Ripening
Feasibility Studies
Hysterectomy
Blood Transfusion
Therapeutics
Referral and Consultation
Databases
Morbidity
sulprostone

Keywords

  • Dilapan
  • Feticide
  • Hemorrhage
  • Mifepristone
  • Misoprostol
  • Placenta previa
  • Termination of pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa - Does feticide decrease postdelivery maternal hemorrhage? / Ruano, Rodrigo; Dumez, Y.; Cabrol, D.; Dommergues, M.

In: Fetal Diagnosis and Therapy, Vol. 19, No. 6, 22.11.2004, p. 475-478.

Research output: Contribution to journalReview article

@article{3f5df7c233e0451f9ea28e57d7cb6ead,
title = "Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa - Does feticide decrease postdelivery maternal hemorrhage?",
abstract = "Objective: To study the feasibility of second- and thirdtrimester termination of pregnancy (TOP) with complete placenta previa, and the impact of performing feticide before labor induction on maternal hemorrhagic morbidity. Patients and Methods: From 1987 to 2002, the databases of two referral hospitals were reviewed. We identified 15 cases of second- or third-trimester TOP in women with complete placenta previa. Feticide was performed 2-14 days before induction in 6/15 cases. Cervical ripening was achieved in 8 cases by mifepristone alone (n = 2) or by mifepristone and dilapan (n = 6). Labor was induced by vaginal gemeprost (n = 2), intramuscular (n = 5) or intravenous (n = 4) sulprostone, vaginal misoprostol (n = 1) or a combination of misoprostol and sulprostone (n = 3). Hemorrhage was defined by the need for transfusion. The difference between the preoperative and the lowest per- or postoperative maternal hemoglobin level was also analyzed. Results: Of the 9 women who underwent labor induction without previous feticide, 4 required blood transfusions, 1 of whom had a hemostat hysterectomy. The mean hemoglobin difference was 2.5 g/dl (range: 0.5-5.3). None of the 6 patients with preinduction feticide required transfusion. The hemoglobin difference was significantly smaller in this group than in terminations without previous feticide (mean: 1.0 g/dl ; range: 0.1-2.2; p = 0.03). Conclusion: In cases with complete placenta previa, second- or third-trimester TOP is feasible. It carries a substantial risk of hemorrhage that might be decreased by preinduction feticide.",
keywords = "Dilapan, Feticide, Hemorrhage, Mifepristone, Misoprostol, Placenta previa, Termination of pregnancy",
author = "Rodrigo Ruano and Y. Dumez and D. Cabrol and M. Dommergues",
year = "2004",
month = "11",
day = "22",
doi = "10.1159/000080157",
language = "English (US)",
volume = "19",
pages = "475--478",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa - Does feticide decrease postdelivery maternal hemorrhage?

AU - Ruano, Rodrigo

AU - Dumez, Y.

AU - Cabrol, D.

AU - Dommergues, M.

PY - 2004/11/22

Y1 - 2004/11/22

N2 - Objective: To study the feasibility of second- and thirdtrimester termination of pregnancy (TOP) with complete placenta previa, and the impact of performing feticide before labor induction on maternal hemorrhagic morbidity. Patients and Methods: From 1987 to 2002, the databases of two referral hospitals were reviewed. We identified 15 cases of second- or third-trimester TOP in women with complete placenta previa. Feticide was performed 2-14 days before induction in 6/15 cases. Cervical ripening was achieved in 8 cases by mifepristone alone (n = 2) or by mifepristone and dilapan (n = 6). Labor was induced by vaginal gemeprost (n = 2), intramuscular (n = 5) or intravenous (n = 4) sulprostone, vaginal misoprostol (n = 1) or a combination of misoprostol and sulprostone (n = 3). Hemorrhage was defined by the need for transfusion. The difference between the preoperative and the lowest per- or postoperative maternal hemoglobin level was also analyzed. Results: Of the 9 women who underwent labor induction without previous feticide, 4 required blood transfusions, 1 of whom had a hemostat hysterectomy. The mean hemoglobin difference was 2.5 g/dl (range: 0.5-5.3). None of the 6 patients with preinduction feticide required transfusion. The hemoglobin difference was significantly smaller in this group than in terminations without previous feticide (mean: 1.0 g/dl ; range: 0.1-2.2; p = 0.03). Conclusion: In cases with complete placenta previa, second- or third-trimester TOP is feasible. It carries a substantial risk of hemorrhage that might be decreased by preinduction feticide.

AB - Objective: To study the feasibility of second- and thirdtrimester termination of pregnancy (TOP) with complete placenta previa, and the impact of performing feticide before labor induction on maternal hemorrhagic morbidity. Patients and Methods: From 1987 to 2002, the databases of two referral hospitals were reviewed. We identified 15 cases of second- or third-trimester TOP in women with complete placenta previa. Feticide was performed 2-14 days before induction in 6/15 cases. Cervical ripening was achieved in 8 cases by mifepristone alone (n = 2) or by mifepristone and dilapan (n = 6). Labor was induced by vaginal gemeprost (n = 2), intramuscular (n = 5) or intravenous (n = 4) sulprostone, vaginal misoprostol (n = 1) or a combination of misoprostol and sulprostone (n = 3). Hemorrhage was defined by the need for transfusion. The difference between the preoperative and the lowest per- or postoperative maternal hemoglobin level was also analyzed. Results: Of the 9 women who underwent labor induction without previous feticide, 4 required blood transfusions, 1 of whom had a hemostat hysterectomy. The mean hemoglobin difference was 2.5 g/dl (range: 0.5-5.3). None of the 6 patients with preinduction feticide required transfusion. The hemoglobin difference was significantly smaller in this group than in terminations without previous feticide (mean: 1.0 g/dl ; range: 0.1-2.2; p = 0.03). Conclusion: In cases with complete placenta previa, second- or third-trimester TOP is feasible. It carries a substantial risk of hemorrhage that might be decreased by preinduction feticide.

KW - Dilapan

KW - Feticide

KW - Hemorrhage

KW - Mifepristone

KW - Misoprostol

KW - Placenta previa

KW - Termination of pregnancy

UR - http://www.scopus.com/inward/record.url?scp=8344265400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8344265400&partnerID=8YFLogxK

U2 - 10.1159/000080157

DO - 10.1159/000080157

M3 - Review article

C2 - 15539869

AN - SCOPUS:8344265400

VL - 19

SP - 475

EP - 478

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 6

ER -